OTTAWA (dpa-AFX) - Shares of Aurinia Pharmaceuticals Inc. (AUPH) (AUP.TO)
were up over 18% on Monday, following encouraging results from a small pilot
study of its lead drug, Voclosporin, as a treatment for active lupus nephritis.
In the study,...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.